Skip to Main Content

Notice of Change in Representative Directors

Osaka, Japan – March 23, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) decided, at the Board of Directors’ meeting held today, to implement changes in Representative Director. The changes will be officially decided at the Company’s Annual General Meeting of Shareholders and the Board of Directors’ meeting scheduled for late June, 2020.

1. Reasons for Changes in Representative Director
As we enter Sawai’s 91st year, we are structuring the Company to achieve enhanced corporate value, sustainable earnings growth and faster decision making.

2. Changes in Representative Director

Name New Title Current Title
Mitsuo Sawai Chairman, Representative Director President, Representative Director
Kenzo Sawai President, Representative Director Director, Senior Managing Executive Officer
Hiroyuki Sawai Supreme Adviser Chairman, Representative Director

3. Career summary of the newly appointed representative directors

Mitsuo Sawai

Name New Title
Apr 1982 Joined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.)
Jan 1989 Joined Sawai
Jun 2000 Director, Deputy Vice President of Sales Division, and General Manager of Sales Planning Department
Jun 2002 Managing Director, Deputy Vice President of Sales Division, and General Manager of Sales Planning Department
Jun 2005 Senior Managing Director, Vice President of Sales Division
Jun 2008 President, Representative Director

 

Kenzo Sawai

Name New Title
Apr 1995 Joined Sumitomo Pharmaceuticals Co., Ltd. (currently Sumitomo Dainippon Pharma Co., Ltd.)
Apr 2001 Joined Sawai
Jun 2010 Director, Vice President of Corporate Strategy Department
Jun 2013 Director, Senior Executive Officer, Vice President of Corporate Strategy Department, and Deputy Vice President of Sales Division
Jun 2017 Director, Senior Managing Executive Officer, Vice President of Corporate Strategy Department and Supervisor of Sales Division, President and Member of the Board of Sawai America LLC (incumbent), Chairman of the Board of Upsher-Smith Laboratories, LLC (incumbent)
Jun 2018 Director, Senior Managing Executive Officer, Vice President of Corporate Strategy Department and Supervisor of Research & Development Division

Contact Information

PR / IR Group, Corporate Strategy Department, Sawai Pharmaceutical Co., Ltd.
E-mail: koho@sawai.co.jp